High-Level Overview
Lacuna Diagnostics, LLC is a veterinary diagnostics startup that developed a cloud-based digital telemedicine platform for point-of-care cytology, enabling veterinarians to upload slide images for rapid interpretation by a global network of over 25 board-certified clinical pathologists.[1][2][3] The platform serves veterinary hospitals worldwide, solving the problem of slow traditional lab pathology by delivering results in minutes instead of days, improving accuracy, confidence in treatment plans, and reducing environmental impact from shipping physical samples.[1][3][4] Founded in 2016 in Fort Collins, Colorado, the company achieved early traction with installations in hospitals across 14 U.S. states, Canada, and Taiwan by 2017-2018, before its acquisition by Heska Corporation in 2021 to expand Heska's point-of-care diagnostics and telemedicine offerings.[1][3][4]
Origin Story
Lacuna Diagnostics emerged from Colorado State University's combined Doctor of Veterinary Medicine/MBA program, where founders Aaron Wallace and Conor Blanchet met in 2014 and identified a critical gap in veterinary diagnostics: the multi-day wait for cytology results from central labs.[4] The name "Lacuna" reflects this vision of filling a "space or gap" in medicine, as Wallace explained, by pioneering cloud-based digital uploads of tissue or fluid slide images for near-instant pathologist review—often while the pet and owner remain in the exam room.[1][4] Key early milestones included its first hospital installation in June 2017, winning the $25,000 Pet Project competition for nationwide exposure, a major investment round, and participation in the 2018 Leap Venture Studio accelerator cohort launched by Michelson Found Animals and Mars Petcare's Kinship.[1][4] By then, founders like Blanchet and others (including references to Koirala and Walz in operations) had transitioned to full-time roles, scaling to over 25,000 interpreted cases with pathologists across the U.S., Canada, Europe, New Zealand, and Australia.[3][4]
Core Differentiators
- First-to-Market Digital Telemedicine Cytology: Lacuna's revolutionary software, workflow, and AI-driven data technology enabled the upload and instant transmission of point-of-care samples to experts, achieving market-leading speed and accuracy ahead of competitors.[1][3]
- Global Expert Network: Access to over 25 board-certified pathologists across multiple time zones ensured 24/7-like coverage and comprehensive interpretations, boosting veterinarian confidence and treatment outcomes.[1][2][3]
- Efficiency and Sustainability Gains: Dramatically cut turnaround from days to minutes, eliminated physical shipping pollution, and supported real-time decisions in-clinic, transforming workflows for hospitals of any size or location.[1][3][4][5]
- Proven Scalability: Handled over 25,000 cases pre-acquisition, with seamless integration into veterinary practices via cloud platform, prioritizing customer service and operational efficiency.[1][3][4]
Role in the Broader Tech Landscape
Lacuna rode the wave of telemedicine and digital diagnostics in pet care, accelerated by a booming U.S. pet industry spending $95.7 billion in 2019 (with $29.3 billion on veterinary care), amid demands for faster, accessible innovation post-2018 pet ecosystem investments.[1] Its timing capitalized on cloud/AI advancements and post-pandemic shifts toward remote veterinary services, filling gaps in point-of-care tools amid traditional lab inefficiencies.[3][4] By partnering with accelerators like Leap Venture Studio and influencing standards through rapid adoption (e.g., in 14 states and internationally), Lacuna advanced animal welfare—aligning with missions from Michelson Found Animals and Mars Petcare—while paving the way for integrated diagnostics in a market favoring tech-enabled pet health equity.[1][4]
Quick Take & Future Outlook
Post-2021 acquisition by Heska (now part of Mars Veterinary Health), Lacuna's technology has likely scaled globally within Heska's advanced diagnostics portfolio, enhancing point-of-care cytology, AI enhancements, and telemedicine integration.[1][3] Trends like AI-driven pathology, rising pet humanization, and sustainable vet tech will propel its evolution, potentially expanding to new modalities or broader companion animal diagnostics. Its influence endures as a pioneer, humanizing pet care through speed and expertise—echoing its founding mission to fill critical gaps and save lives faster.[1][3][7]
